Skip to main content

$0.056 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
11 October 2024 at 3:07am
Register to track CDY and receive email alerts.

Cellmid Limited, a consumer health company, develops, manufactures, and markets anti-aging products for hair, skin, and wellbeing in Australia, the United States, China, and Japan. It develops and sales FGF5 inhibitor hair health and hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. In addition, the company markets its products through retailers and wholesalers, as well as through a direct-to-consumer, e-commerce platform. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.

Expand Company Description

Market Cap (15-Feb)

$12,332,152 (1,885th)

Close (15-Dec)

$0.056

Volume (15-Dec)

0

Shortsold (8-Dec)

13,278 (0.02%) (428th)

52w High

$0.000

52w Low

$0.000

P/E

-

EPS

-0.024
Subject
CDY Ann: Results of Meeting

CDY Ann: AGM Presentation to Shareholders

CDY Ann: Release of Shares from Voluntary Escrow

CDY Ann: Cellmid receives R&D tax credit

CDY Ann: Proposed issue of securities - CDY

CDY Ann: Letter to Shareholders - Notice of Annual General Meeting

CDY Ann: Notice of Annual General Meeting/Proxy Form

CDY Ann: Jobkeeper Payments Notification

CDY Ann: Initial Director's Interest Notice - Christopher

CDY Ann: Final Director's Interest Notice - Eck-Thompson

CDY Ann: Becoming a substantial holder from HNG

CDY Ann: Appointment of Non-Executive Director

CDY Ann: Cleansing Notice

CDY Ann: Application for quotation of securities - CDY

CDY Ann: BLC Cosmetics Acquisition Completed

CDY Ann: Results of Meeting

CDY Ann: General Meeting Presentation

CDY Ann: Appendix 4C and Quarterly Activity Report

CDY Ann: Notification of cessation of securities - CDY

CDY Ann: Investor Webinar

CDY Ann: Change of Director's Interest Notice - Halasz

CDY Ann: Letter to Shareholders - Notice of General Meeting

CDY Ann: Notice of General Meeting/Proxy Form

CDY Ann: Appendix 4G and Corporate Governance Statement

CDY Ann: Annual Report to shareholders

CDY Ann: HNG: BLC Cosmetics to merge with Cellmid

CDY Ann: Proposed issue of securities - CDY

CDY Ann: Cellmid to Acquire BLC Cosmetics Pty Ltd

CDY Ann: Appendix 4E and FY21 Financial Report

CDY Ann: Appendix 4C and Quarterly Activity Report

CDY Ann: Notification of cessation of securities - CDY

CDY Ann: MarketLit Investor Conference Presentation

CDY Ann: Cellmid Reports Record QVC Sales

CDY Ann: Release of Shares from Voluntary Escrow

CDY Ann: FGF5 Inhibitors Supply Agreement - Additional Information

CDY Ann: Supply Agreement for Cellmid's FGF5 Inhibitors

CDY Ann: Investor Briefing and Presentation

CDY Ann: Chinese Import Permits Received

CDY Ann: Investor Briefing

CDY Ann: Agreement Signed for Sale of Lyramid Limited

CDY Ann: Appendix 4C and Quarterly Activity Report

CDY Ann: Change of Director's Interest Notice - Eck

CDY Ann: Change of Director's Interest Notice - Cross

CDY Ann: Change of Director's Interest Notice - Halasz

CDY Ann: Change of Director's Interest Notice - Gordon

CDY Ann: CDYOA Top20 and Distribution List

CDY Ann: Appendix 2A

CDY Ann: Supplementary Prospectus

CDY Ann: Proposed issue of Securities - CDY

CDY Ann: Rights Issue Closed with Strong Demand

Register to track CDY and receive email alerts.

Similar Companies

CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX